Algorithms and working party guidelines

Guidelines algorithms are developed for healthcare professionals working in primary and shared care. They are put together by clinical experts to meet a clinical need that is not currently covered by national guidance. Items may contain pharmaceutical promotional information.

Anticholinergics and cognitive impairment in the treatment of overactive bladder

Commissioned by Contura Ltd

This management algorithm has been commissioned and funded by Contura Ltd and developed in partnership with Guidelines. Information intended for UK healthcare professionals.
View adverse event reporting and prescribing information

REG/2020/224 September 2020

Identifying and managing allergic rhinitis in the asthma population

By Development Group—Scadding Holmes Ryan and Williams

This management algorithm was developed by a multidisciplinary expert panel: Scadding et al with the support of an educational grant from Mylan.

Osteoporotic fracture guideline

By Working party—Cooper Javaid Elliott Stephens Tanna

This guideline was developed by a multidisciplinary expert panel: Cooper C et al with the support of an educational grant from UCB Pharma Ltd.

Inhaler choice guideline

By Development group—Usmani Capstick Saleem Scullion

This management algorithm was developed by a multidisciplinary expert panel: Usmani et al and supported by Chiesi Ltd through the provision of a grant for its production.

Women of child-bearing age with inflammatory rheumatic diseases guideline

By Working party—Giles Allen Nelson-Piercy Tower Warburton Gordon

This guideline was developed by a multidisciplinary expert panel: Giles I et al with the support of an educational grant from UCB Pharma Ltd.

Consensus guideline on the holistic management of patients requiring anticoagulation

By Working party–Fay Antoniou Martins Merriman Patrickson Uprichard

This guideline was developed by a multidisciplinary expert panel: Fay M et al with the support of an educational grant from Bayer plc.

Guideline for the managed introduction of biosimilar basal insulin

By Working party—Down Beba Brown Diggle Goel Milne

This guideline was developed by a multidisciplinary expert panel: Down S et al with the support of an educational grant from Mylan.

Medication management of patients with enteral feeding tubes

By Working party—Wright Griffith Merriman Smithard Smyth Welsh

This guideline was developed by a multidisciplinary expert panel: Wright D et al with the support of a grant from Rosemont Pharmaceuticals Ltd.

Uncomplicated recurrent UTI guideline

By Working party—Rees Brocksom Harding Jacobson Rollinson

This guideline was developed by a multidisciplinary expert panel: Rees J et al with the support of a grant from Aspire Pharma Ltd.

Non-vitamin K oral anticoagulant options for patients with non-valvular atrial fibrillation and renal impairment

Commissioned by Bayer plc

This NOAC dosing guide has been commissioned by Bayer, who also provided funding for its development. Bayer reviewed and approved the scope and pre-meeting documents, suggested the Chair and experts for the group, and put the dosing guide through full medical approval to ensure its compliance with appropriate regulations.